secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001753926-25-001710
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Q3 2025: Revenue down 21.6% to $6.9M; net loss of $0.9M vs profit of $1.2M a year ago
--------------------------------------------------------------------------------

- Net loss of $0.9M ($0.06 per share) vs net income of $1.2M ($0.07 diluted) in Q3 2024.
- Revenue fell 21.6% to $6.9M; gross margin dropped to 39.1% from 59.1%.
- Shipped 16 SRT systems (vs 27 last year), including 3 to China; 21 FDA sites active.
- CMS published first-ever dedicated CPT® codes for SRT, improving reimbursement certainty.
- Exited quarter with $24.5M cash, no debt; nearly 100 systems in inventory.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000175392625001710/0001753926-25-001710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000175392625001710/g084998_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-001710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer